AdaptHealth will divest its Diabetes Health business to Cardinal Health for $235 million in cash (subject to customary purchase price adjustments). The transaction is a portfolio reshaping move that should improve focus and potentially unlock value for AHCO shareholders. Impact is likely most concentrated in the two stocks rather than the broader market.
AdaptHealth will divest its Diabetes Health business to Cardinal Health for $235 million in cash (subject to customary purchase price adjustments). The transaction is a portfolio reshaping move that should improve focus and potentially unlock value for AHCO shareholders. Impact is likely most concentrated in the two stocks rather than the broader market.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
